LAM-001
Phase 1- Indications
- Lymphangioleiomyomatosis
Company intelligence / Profile preview
L.A.M. Pharmaceutical Corp.
Delaware, USAlamtherapeutics.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
LAM Pharmaceutical Corp. developed a proprietary Ionic Polymer Matrix technology aimed at enhancing transdermal drug delivery for both prescription and OTC drugs, with a focus on wound healing applications such as slow-healing diabetic ulcers. The company underwent several restructurings, acquisitions, and ultimately changed its name to Easton Pharmaceuticals Inc., shifting its business direction.[1][2][3]
- Therapeutic areas
- OtherEndocrinology
- Modalities
- Drug delivery systems (Ionic Polymer Matrix technology for transdermal drug delivery)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Multinational corporate collaborator involved in clinical review of wound-healing patch data; specific names not disclosed.[2]
Beyond the preview
Go deeper on L.A.M. Pharmaceutical Corp..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on L.A.M. Pharmaceutical Corp..